Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24770722)

  • 1. Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer.
    Lee SJ; Kang BW; Chae YS; Kim HJ; Park SY; Park JS; Choi GS; Jeon HS; Lee WK; Kim JG
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S634-9. PubMed ID: 24770722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
    Slattery ML; Herrick JS; Lundgreen A; Fitzpatrick FA; Curtin K; Wolff RK
    Carcinogenesis; 2010 Sep; 31(9):1604-11. PubMed ID: 20622004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
    Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
    PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Kang BW; Moon JH; Lee SJ; Jeon SW; Park JS; Park JY; Choi GS
    Oncology; 2010; 79(3-4):278-82. PubMed ID: 21412012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes.
    Keshavarz P; Inoue H; Nakamura N; Yoshikawa T; Tanahashi T; Itakura M
    Mol Genet Metab; 2008 Feb; 93(2):200-9. PubMed ID: 17950019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer.
    Chen M; Jiang B; He B; Tang M; Wang P; Chen L; Lu J; Lu P
    BMC Cancer; 2018 Sep; 18(1):923. PubMed ID: 30253744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
    Slattery ML; Lundgreen A; Herrick JS; Caan BJ; Potter JD; Wolff RK
    Nutr Cancer; 2011 Nov; 63(8):1226-34. PubMed ID: 21999454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVS10+12A>G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Moon JH; Kang BW; Park JY; Jeon SW; Lee MH; Lim KH; Choi GS; Jun SH
    Ann Oncol; 2010 Mar; 21(3):525-529. PubMed ID: 19759184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in microRNA-binding site and prognosis of patients with colorectal cancer.
    Kim JG; Chae YS; Lee SJ; Kang BW; Park JY; Lee EJ; Jeon HS; Park JS; Choi GS
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):35-41. PubMed ID: 25079514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations in the PRKAA1 and ZBTB20 genes and gastric cancer susceptibility in a Korean population.
    Song HR; Kim HN; Kweon SS; Choi JS; Shim HJ; Cho SH; Chung IJ; Park YK; Kim SH; Choi YD; Joo KW; Shin MH
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E155-60. PubMed ID: 23861218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered LKB1/AMPK/TSC1/TSC2/mTOR signaling causes disruption of Sertoli cell polarity and spermatogenesis.
    Tanwar PS; Kaneko-Tarui T; Zhang L; Teixeira JM
    Hum Mol Genet; 2012 Oct; 21(20):4394-405. PubMed ID: 22791749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the polymorphisms in the hypoxia pathway genes in relation to outcome in colorectal cancer.
    Haja Mohideen AM; Hyde A; Squires J; Wang J; Dicks E; Younghusband B; Parfrey P; Green R; Savas S
    PLoS One; 2014; 9(11):e113513. PubMed ID: 25405996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
    Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
    Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LKB1 loss at transcriptional level promotes tumor malignancy and poor patient outcomes in colorectal cancer.
    He TY; Tsai LH; Huang CC; Chou MC; Lee H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S703-10. PubMed ID: 24879590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer.
    Lee SY; Jin CC; Choi JE; Hong MJ; Jung DK; Do SK; Baek SA; Kang HJ; Kang HG; Choi SH; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Lee YM; Lee IK; Jheon S; Park JY
    Sci Rep; 2016 Oct; 6():35603. PubMed ID: 27767175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
    Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A
    PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plk2 Loss Commonly Occurs in Colorectal Carcinomas but not Adenomas: Relationship to mTOR Signaling.
    Matthew EM; Yang Z; Peri S; Andrake M; Dunbrack R; Ross E; El-Deiry WS
    Neoplasia; 2018 Mar; 20(3):244-255. PubMed ID: 29448085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EGFR SNPs in survival of advanced lung adenocarcinoma patients treated with Gefitinib.
    Zhang L; Yuan X; Chen Y; Du XJ; Yu S; Yang M
    Gene; 2013 Mar; 517(1):60-4. PubMed ID: 23313300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implication of TSC1 and mTOR expression in gastric carcinoma.
    Byeon SJ; Han N; Choi J; Kim MA; Kim WH
    J Surg Oncol; 2014 Jun; 109(8):812-7. PubMed ID: 24615476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.